3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
Fluorodeoxyglucose F18
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tanespimycin
1
romidepsin
1
pembrolizumab
1
omipalisib
1
durvalumab
1
dabrafenib
1
cediranib
1
aflibercept
1
Vorinostat
1
Thyrotropin Alfa
1
Specimen Handling
1
Sorafenib
1
Pharmacogenomic Testing
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Iodine-124
1
Gefitinib
1
Decitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Follicular
×
Phantoms, Imaging
×
Clear all
No trials found.